| Blonie Wayne Dudney Jr, MD | |
|
1224 Graham Rd, 3011, Florissant, MO 63031-8028 | |
| (314) 839-1211 | |
| (314) 839-8429 |
| Full Name | Blonie Wayne Dudney Jr |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 20 Years |
| Location | 1224 Graham Rd, Florissant, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003019019 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0107X | Ophthalmology - Retina Specialist | 2010014075 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina Associates Of St Louis, Inc | 3577522101 | 4 |
News Archive
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
Neurons derived from two different types of precursor cells that later develop into neurons in the medial amygdala - one of the interconnected structures in the brain involved in emotion, motivation and memory - help to program innate reproductive and aggressive behaviors into the brain, research led by Children's National Health System indicates.
UK cancer research is helping to deliver significant clinical improvements for cancer patients, according to a study published in the British Journal of Cancer.
Intrinsic Bioprobes Inc. ("IBI") today announced the launch of its first mass spectrometry-based protein assays for in-vitro diagnostic testing. The assays for beta-2-microglobulin, cystatin C, and retinol binding protein are performed on IBI's MASSAY® platform at the CLIA-certified and College of American Pathology (CAP) accredited diagnostic laboratory of the Institute of Genomics Medicine, UMDNJ-New Jersey Medical School.
› Verified 6 days ago
| Entity Name | Retina Associates Of St Louis, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750581666 PECOS PAC ID: 3577522101 Enrollment ID: O20041008000000 |
News Archive
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
Neurons derived from two different types of precursor cells that later develop into neurons in the medial amygdala - one of the interconnected structures in the brain involved in emotion, motivation and memory - help to program innate reproductive and aggressive behaviors into the brain, research led by Children's National Health System indicates.
UK cancer research is helping to deliver significant clinical improvements for cancer patients, according to a study published in the British Journal of Cancer.
Intrinsic Bioprobes Inc. ("IBI") today announced the launch of its first mass spectrometry-based protein assays for in-vitro diagnostic testing. The assays for beta-2-microglobulin, cystatin C, and retinol binding protein are performed on IBI's MASSAY® platform at the CLIA-certified and College of American Pathology (CAP) accredited diagnostic laboratory of the Institute of Genomics Medicine, UMDNJ-New Jersey Medical School.
› Verified 6 days ago
| Entity Name | Retina Contracting Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023400058 PECOS PAC ID: 9931427374 Enrollment ID: O20160908002448 |
News Archive
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
Neurons derived from two different types of precursor cells that later develop into neurons in the medial amygdala - one of the interconnected structures in the brain involved in emotion, motivation and memory - help to program innate reproductive and aggressive behaviors into the brain, research led by Children's National Health System indicates.
UK cancer research is helping to deliver significant clinical improvements for cancer patients, according to a study published in the British Journal of Cancer.
Intrinsic Bioprobes Inc. ("IBI") today announced the launch of its first mass spectrometry-based protein assays for in-vitro diagnostic testing. The assays for beta-2-microglobulin, cystatin C, and retinol binding protein are performed on IBI's MASSAY® platform at the CLIA-certified and College of American Pathology (CAP) accredited diagnostic laboratory of the Institute of Genomics Medicine, UMDNJ-New Jersey Medical School.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Blonie Wayne Dudney Jr, MD 1224 Graham Rd, 3011, Florissant, MO 63031-8028 Ph: (314) 839-1211 | Blonie Wayne Dudney Jr, MD 1224 Graham Rd, 3011, Florissant, MO 63031-8028 Ph: (314) 839-1211 |
News Archive
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
Neurons derived from two different types of precursor cells that later develop into neurons in the medial amygdala - one of the interconnected structures in the brain involved in emotion, motivation and memory - help to program innate reproductive and aggressive behaviors into the brain, research led by Children's National Health System indicates.
UK cancer research is helping to deliver significant clinical improvements for cancer patients, according to a study published in the British Journal of Cancer.
Intrinsic Bioprobes Inc. ("IBI") today announced the launch of its first mass spectrometry-based protein assays for in-vitro diagnostic testing. The assays for beta-2-microglobulin, cystatin C, and retinol binding protein are performed on IBI's MASSAY® platform at the CLIA-certified and College of American Pathology (CAP) accredited diagnostic laboratory of the Institute of Genomics Medicine, UMDNJ-New Jersey Medical School.
› Verified 6 days ago
Dr. Clayton Greer Scanlon, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1224 Graham Rd, 3011, Florissant, MO 63031 Phone: 314-839-1211 Fax: 314-893-8429 | |
Julie Marie Sturm, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 900 N Hwy 67, Florissant, MO 63031 Phone: 314-838-0300 Fax: 314-838-4682 | |
John Paul Goltschman, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 900 N Hwy 67, Florissant, MO 63031 Phone: 314-838-0300 Fax: 314-838-4682 | |
Carla Territo, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1224 Graham Rd, Suite 3011, Florissant, MO 63031 Phone: 314-839-1211 | |
David A. Glaser, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1224 Graham Rd, Suite 3011, Florissant, MO 63031 Phone: 314-839-1211 | |
Stephen E Kraft, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1150 Graham Rd, Ste 107, Florissant, MO 63031 Phone: 314-837-3667 Fax: 314-837-3728 |